表紙:補聴器の世界市場 (~2026年):製品タイプ (補聴器 (RIE・BTE・ITE)・インプラント (人工内耳・骨埋め込み型))・難聴区分 (感音性・伝音性)・患者区分 (成人・小児)・地域別
市場調査レポート
商品コード
1021570

補聴器の世界市場 (~2026年):製品タイプ (補聴器 (RIE・BTE・ITE)・インプラント (人工内耳・骨埋め込み型))・難聴区分 (感音性・伝音性)・患者区分 (成人・小児)・地域別

Hearing Aids Market by Product Type [Aids (Receiver,Behind the Ear, In the Canal, In the Ear Aids), Implants (Cochlear, Bone-anchored)], Type of Hearing Loss (Sensorineural, Conductive), Patient Type (Adults, Pediatrics), Region-Global Forecast to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 230 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.12円
補聴器の世界市場 (~2026年):製品タイプ (補聴器 (RIE・BTE・ITE)・インプラント (人工内耳・骨埋め込み型))・難聴区分 (感音性・伝音性)・患者区分 (成人・小児)・地域別
出版日: 2021年07月30日
発行: MarketsandMarkets
ページ情報: 英文 230 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の補聴器の市場規模は予測期間中6.4%のCAGRで推移し、2021年の75億米ドルから、2026年には102億米ドルの規模に成長すると予測されています。

騒音性難聴の発生率の上昇によるスマート補聴器の導入の増加、難聴の有病率の上昇、補聴器の技術的進歩などの要因が同市場の成長を推進しています。一方で、価格の高さや、高額な設備投資が必要であることなどが市場のさらなる成長を妨げる大きな要因となっています。

製品別では、聴覚インプラントの部門が予測期間中最大の成長を示すと予測されています。聴覚障害の発生率の高さ、聴覚インプラントの技術的進歩、高齢者人口の増加などの要因が同部門の成長を牽引しています。また、難聴区分別では、感音難聴の部門が最大のCAGRを示すと予測されています。

当レポートでは、世界の補聴器の市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、疫学的データ、法規制環境、技術・特許の分析、ケーススタディ、市場規模の推移・予測、製品・難聴区分・患者区分・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • 疫学データ
  • COVID-19の影響
  • ケーススタディ
  • シナリオ分析
  • 価格分析
  • 特許分析
  • 貿易分析
  • バリューチェーン
  • サプライチェーン分析
  • エコシステム分析
  • ポーターのファイブフォース分析
  • 規制状況
  • 技術分析
  • 顧客の事業に影響を与える動向

第6章 市場分析・予測:製品別

  • 補聴器
    • RIE(レシーバー耳かけ型)
    • BTE (耳かけ型)
    • カナル型補聴器
    • ITE(耳あな型)
    • その他
  • 聴覚インプラント
    • 人工内耳
    • 骨固定システム

第7章 市場分析・予測:難聴区分別

  • 感音難聴
  • 伝音難聴

第8章 市場分析・予測:患者区分別

  • 成人
  • 小児

第9章 市場分析・予測:地域・主要国別

  • 欧州
  • 北米
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 主要企業の戦略
  • 主要企業の収益シェア分析
  • 市場シェア分析
  • 企業評価クアドラント
  • 新興企業/中小企業の競合リーダーシップマッピング
  • 競合ベンチマーキング
  • 競合シナリオ

第11章 企業プロファイル

  • 主要企業
    • SONOVA GROUP
    • DEMANT A/S
    • GN STORE NORD A/S
    • COCHLEAR LTD.
    • RION CO., LTD.
    • STARKEY
    • WS AUDIOLOGY A/S
    • NUROTRON BIOTECHNOLOGY CO., LTD.
    • MED-EL
    • AUDINA HEARING INSTRUMENTS, INC.
    • ELKON PVT. LTD.
  • 他の有力企業
    • EARGO, INC.
    • HORENTEK
    • ZOUNDS HEARING INC.
    • SEBOTEK HEARING SYSTEMS, LLC.
    • ARPHI ELECTRONICS PRIVATE LIMITED
    • IN4 TECHNOLOGY CORPORATION
    • BHM-TECH PRODUKTIONSGESELLSCHAFT MBH
    • NANO HEARING AIDS
    • LORECA S.R.O.
    • EARLENS CORPORATION
    • AUSTAR HEARING SCIENCE AND TECHNOLOGY(XIAMEN)CO., LTD.
    • LIVELY HEARING CORPORATION
    • AUDIFON GMBH & CO. KG
    • FOSHAN VOHOM TECHNOLOGY CO., LTD.

第12章 付録

目次
Product Code: MD 3864

The global hearing aids market is projected to reach USD 10.2 billion by 2026 from USD 7.5billion in 2021, at a CAGR of 6.4% during the forecast period. Market growth is driven by factors such as the increasing adoption of smart hearing aids due to the rising incidence of noise-induced hearing loss, the growing prevalence of hearing loss, and technological advancements in hearing aids. On the other hand, the high cost of hearing aids and the requirement of high capital investments are the major factors hampering the growth of this market.

"The hearing implantssegment accounted for the highest growth rate in thehearing aidsmarket, by product, during the forecast period"

The hearing aids market is segmented into hearing aid devices and hearing implants based on product. In 2020, the hearing implants segment accounted for the highest growth rate in the hearing aids market.The high incidence of hearing disorders, technological advancements in hearing implants, and growth in the geriatric population are the major factors contributing to the growth of this segment. However, the high cost of these implants and the low awareness about hearing implants in emerging countries are some of the major factors that are hindering the growth of this market segment.

"Sensorineural hearing loss segment accounted for the highest CAGR"

Based on the type of hearing loss, the hearing aids market is segmented into sensorineural hearing loss and conductive hearing loss. In 2020, the sensorineural hearing loss segment accounted for the highest growth rate. This can be attributed to thehigh prevalence of sensorineural hearing loss, coupled with the growing geriatric patient pool.

"Asia Pacific: The fastest-growing regionhearing aids market"

The global hearing aids market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period.Factors such as the increasing prevalence of hearing loss, increasing healthcare spending, growing per capita income, and the presence of several high-growth marketsare driving the growth of the hearing aids market in this region. The low labor costs and the favorable regulatory environment in this region are also expected to propel the market growth.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%,and Tier 3 -30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America -51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and the Middle East & Africa - 4%

Lists of Companies Profiled in the Report:

  • Sonova Group (Switzerland)
  • Demant A/S (Denmark)
  • GN Store Nord A/S (Denmark)
  • Cochlear Ltd. (Australia)
  • RION Co., Ltd. (Japan)
  • Starkey (US)
  • Nurotron Biotechnology Co., Ltd. (China)
  • MED-EL (Austria)
  • Audina Hearing Instruments, Inc. (US)
  • ElkonPvt. Ltd. (India)
  • WS Audiology A/S (Denmark)
  • Eargo, Inc. (US)
  • Horentek (Italy)
  • ZOUNDS Hearing Inc. (US)
  • SeboTek Hearing Systems, LLC. (US)
  • Arphi Electronics Private Limited (India)
  • IN4 Technology Corporation (China)
  • BHM-Tech ProduktionsgesellschaftmbH (Austria)
  • Nano Hearing Aids (US)
  • LORECas.r.o. (Turkey)
  • Earlens Corporation (US)
  • Austar Hearing Science and Technology (Xiamen) Co., Ltd. (China)
  • Lively Hearing Corporation (US)
  • audifon GmbH & Co. KG (Germany)
  • Foshan Vohom Technology Co., Ltd. (China)

Research Coverage:

This report provides a detailed picture of the global hearing aidsmarket. It aims at estimating the size and future growth potential of the market across different segments, such as product, type of hearing loss, patient type,and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall hearing aids market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 HEARING AIDS MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 2 HEARING AIDS MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key data from primary sources
      • 2.2.2.3 Key industry insights
      • 2.2.2.4 Breakdown of primary interviews
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (HEARING AIDS MARKET)
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
      • 2.3.1.2 Approach 2: Market estimation from the parent market
    • FIGURE 6 BOTTOM-UP APPROACH: MARKET ESTIMATION FROM THE PARENT MARKET
      • 2.3.1.3 Approach 3: Presentations of companies and primary interviews
      • 2.3.1.4 Growth rate assumptions
      • 2.3.1.5 CAGR projections
    • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 8 HEARING AIDS MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 LIMITATIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 1 RISKS ASSESSMENT
  • 2.8 COVID-19 HEALTH ASSESSMENT
  • 2.9 COVID-19 ECONOMIC ASSESSMENT
    • FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
  • 2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE HEARING AIDS MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 11 HEARING AIDS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 HEARING AIDS MARKET, BY PATIENT TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 HEARING AIDS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 HEARING AIDS MARKET OVERVIEW
    • FIGURE 15 RISING PREVALENCE OF HEARING LOSS TO DRIVE THE MARKET GROWTH
  • 4.2 HEARING AIDS MARKET SHARE, BY PRODUCT, 2021 VS. 2026
    • FIGURE 16 HEARING AID DEVICES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
  • 4.3 HEARING AIDS MARKET SHARE, BY TYPE OF HEARING LOSS, 2021 VS. 2026
    • FIGURE 17 SENSORINEURAL HEARING LOSS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • 4.4 HEARING AIDS MARKET SHARE, BY PATIENT TYPE, 2021 VS. 2026
    • FIGURE 18 ADULT PATIENTS SEGMENT TO CONTINUE TO DOMINATE THE MARKET IN 2026
  • 4.5 HEARING AIDS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE HEARING AIDS MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 HEARING AIDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing prevalence of hearing loss
    • FIGURE 21 ESTIMATED NUMBER OF PEOPLE WITH DISABLING HEARING LOSS, GLOBALLY
    • FIGURE 22 PREVALENCE OF HEARING LOSS, BY REGION, 2019
        • 5.2.1.1.1 Growth in the geriatric population
    • FIGURE 23 SHARE OF THE GLOBAL POPULATION AGED 65 AND ABOVE (2015-2019)
      • 5.2.1.2 Technological advancements in hearing aids
      • 5.2.1.3 Increasing adoption of smart hearing aids due to the rising incidence of noise-induced hearing loss
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of hearing aids
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets offer lucrative opportunities
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of trained professionals
  • 5.3 EPIDEMIOLOGY DATA ON HEARING LOSS AND THE ADOPTION OF HEARING AID DEVICES
    • TABLE 2 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020, BY AGE GROUP
    • TABLE 3 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020, BY AGE GROUP (10-YEAR RANGE)
    • TABLE 4 GLOBAL NUMBER OF PEOPLE USING HEARING AID DEVICES, BY AGE GROUP
  • 5.4 IMPACT OF COVID-19 ON THE HEARING AIDS MARKET
  • 5.5 CASE STUDY ANALYSIS
    • 5.5.1 CASE STUDY 1: FINDING A NEW WAY TO LISTEN TO CUSTOMERS
    • 5.5.2 CASE STUDY 2: EFFECTIVE SERVICE DELIVERY MODELS AND REGULATIONS CAN IMPROVE ACCESS TO HEARING AIDS
    • 5.5.3 CASE STUDY 3: OVER-THE-COUNTER HEARING AID DELIVERY CAN IMPROVE ACCESSIBILITY AND AFFORDABILITY
  • 5.6 PESSIMISTIC AND OPTIMISTIC SCENARIOS
    • 5.6.1 HEARING AIDS MARKET
    • FIGURE 24 PESSIMISTIC SCENARIO
    • FIGURE 25 OPTIMISTIC SCENARIO
  • 5.7 PRICING ANALYSIS
    • TABLE 5 PRICE OF HEARING AIDS (2021)
  • 5.8 PATENT ANALYSIS
    • 5.8.1 PATENT ANALYSIS OF COCHLEAR IMPLANTS
  • 5.9 TRADE ANALYSIS
    • 5.9.1 TRADE ANALYSIS FOR HEARING AIDS
    • TABLE 6 IMPORT DATA FOR HEARING AIDS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 7 EXPORT DATA FOR HEARING AIDS, BY COUNTRY, 2016-2020 (USD MILLION)
  • 5.10 VALUE CHAIN ANALYSIS
    • FIGURE 26 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
    • 5.10.1 HEARING AID DEVICES VALUE CHAIN IN THE PRIVATE SECTOR
    • TABLE 8 HEARING AID DEVICES VALUE CHAIN IN THE PRIVATE SECTOR
  • 5.11 SUPPLY CHAIN ANALYSIS
    • FIGURE 27 HEARING AIDS MARKET: SUPPLY CHAIN ANALYSIS
  • 5.12 ECOSYSTEM ANALYSIS OF THE HEARING AIDS MARKET
    • FIGURE 28 HEARING AIDS MARKET: ECOSYSTEM ANALYSIS
    • 5.12.1 ROLE IN ECOSYSTEM
  • 5.13 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 9 HEARING AIDS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.13.1 THREAT OF NEW ENTRANTS
    • 5.13.2 THREAT OF SUBSTITUTES
    • 5.13.3 BARGAINING POWER OF BUYERS
    • 5.13.4 BARGAINING POWER OF SUPPLIERS
    • 5.13.5 DEGREE OF COMPETITION
  • 5.14 REGULATORY LANDSCAPE
    • 5.14.1 NORTH AMERICA
      • 5.14.1.1 US
      • 5.14.1.2 Canada
    • 5.14.2 EUROPE
    • 5.14.3 ASIA PACIFIC
      • 5.14.3.1 Japan
      • 5.14.3.2 India
    • 5.14.4 LATIN AMERICA
      • 5.14.4.1 Brazil
      • 5.14.4.2 Mexico
    • 5.14.5 MIDDLE EAST
  • 5.15 TECHNOLOGY ANALYSIS
  • 5.16 TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS
    • 5.16.1 REVENUE SOURCES ARE SHIFTING TOWARD MORE TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC
    • 5.16.2 REVENUE SHIFT FOR THE HEARING AIDS MARKET

6 HEARING AIDS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 10 HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 11 HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
  • 6.2 HEARING AID DEVICES
    • TABLE 12 KEY PRODUCTS IN THE HEARING AID DEVICES MARKET
    • TABLE 13 HEARING AID DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 14 HEARING AID DEVICES MARKET, BY REGION, 2020-2026 (USD MILLION)
    • TABLE 15 HEARING AID DEVICES MARKET, BY REGION, 2016-2019 (MILLION UNITS)
    • TABLE 16 HEARING AID DEVICES MARKET, BY REGION, 2020-2026 (MILLION UNITS)
    • TABLE 17 NORTH AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY, 2016-2019 (MILLION UNITS)
    • TABLE 18 NORTH AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY, 2020-2026 (MILLION UNITS)
    • TABLE 19 EUROPE: HEARING AID DEVICES MARKET, BY COUNTRY, 2016-2019 (MILLION UNITS)
    • TABLE 20 EUROPE: HEARING AID DEVICES MARKET, BY COUNTRY, 2020-2026 (MILLION UNITS)
    • TABLE 21 APAC: HEARING AID DEVICES MARKET, BY COUNTRY, 2016-2019 (MILLION UNITS)
    • TABLE 22 APAC: HEARING AID DEVICES MARKET, BY COUNTRY, 2020-2026 (MILLION UNITS)
    • TABLE 23 HEARING AID DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 24 HEARING AID DEVICES MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 25 HEARING AID DEVICES MARKET, BY TYPE, 2016-2019 (MILLION UNITS)
    • TABLE 26 HEARING AID DEVICES MARKET, BY TYPE, 2020-2026 (MILLION UNITS)
    • 6.2.1 RECEIVER-IN-THE-EAR HEARING AIDS
      • 6.2.1.1 RITE hearing aid devices are suitable for the treatment of mild-to-severe hearing loss
    • TABLE 27 KEY PRODUCTS IN THE RECEIVER-IN-THE-EAR HEARING AIDS MARKET
    • TABLE 28 RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 29 RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • TABLE 30 EUROPE: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 31 EUROPE: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 32 NORTH AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 33 NORTH AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 34 APAC: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 35 APAC: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • 6.2.2 BEHIND-THE-EAR HEARING AIDS
      • 6.2.2.1 Low cost of BTE devices to support the market growth
    • TABLE 36 KEY PRODUCTS IN THE BEHIND-THE-EAR HEARING AIDS MARKET
    • TABLE 37 BEHIND-THE-EAR HEARING AIDS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 38 BEHIND-THE-EAR HEARING AIDS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • TABLE 39 APAC: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 40 APAC: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 41 NORTH AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 42 NORTH AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 43 EUROPE: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 44 EUROPE: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • 6.2.3 CANAL HEARING AIDS
      • 6.2.3.1 Technological advancements in canal hearing aids to propel market growth
    • TABLE 45 KEY PRODUCTS IN THE CANAL HEARING AIDS MARKET
    • TABLE 46 CANAL HEARING AIDS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 47 CANAL HEARING AIDS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • TABLE 48 NORTH AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 49 NORTH AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 50 EUROPE: CANAL HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 51 EUROPE: CANAL HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 52 APAC: CANAL HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 53 APAC: CANAL HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • 6.2.4 IN-THE-EAR HEARING AIDS
      • 6.2.4.1 Longer battery life of ITE hearing devices to support the market growth
    • TABLE 54 IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 55 IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • TABLE 56 EUROPE: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 57 EUROPE: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 58 APAC: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 59 APAC: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 60 NORTH AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 61 NORTH AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • 6.2.5 OTHER HEARING AID DEVICES
    • TABLE 62 OTHER HEARING AID DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 63 OTHER HEARING AID DEVICES MARKET, BY REGION, 2020-2026 (USD MILLION)
    • TABLE 64 EUROPE: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 65 EUROPE: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 66 NORTH AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 67 NORTH AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 68 APAC: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 69 APAC: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
  • 6.3 HEARING IMPLANTS
    • TABLE 70 HEARING IMPLANTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 71 HEARING IMPLANTS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • TABLE 72 EUROPE: HEARING IMPLANTS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 73 EUROPE: HEARING IMPLANTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 74 NORTH AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 75 NORTH AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 76 APAC: HEARING IMPLANTS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 77 APAC: HEARING IMPLANTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 78 HEARING IMPLANTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 79 HEARING IMPLANTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • 6.3.1 COCHLEAR IMPLANTS
      • 6.3.1.1 Cochlear implants segment to dominate the hearing implants market
    • TABLE 80 KEY PRODUCTS IN THE COCHLEAR IMPLANTS MARKET
    • TABLE 81 COCHLEAR IMPLANTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 82 COCHLEAR IMPLANTS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • TABLE 83 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 84 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 85 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 86 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 87 APAC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 88 APAC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • 6.3.2 BONE-ANCHORED SYSTEMS
      • 6.3.2.1 BAHA implants are gaining traction among children and adults with single-sided deafness and conductive hearing loss
    • TABLE 89 BONE-ANCHORED SYSTEMS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 90 BONE-ANCHORED SYSTEMS MARKET, BY REGION, 2020-2026 (USD MILLION)
    • TABLE 91 EUROPE: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 92 EUROPE: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 93 NORTH AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 94 NORTH AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 95 APAC: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 96 APAC: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)

7 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS

  • 7.1 INTRODUCTION
    • TABLE 97 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 98 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
  • 7.2 SENSORINEURAL HEARING LOSS
    • 7.2.1 GROWING GERIATRIC PATIENT POOL TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
      • 7.2.1.1 Primary notes
        • 7.2.1.1.1 Key industry insights
    • TABLE 99 HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 100 HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION, 2020-2026 (USD MILLION)
  • 7.3 CONDUCTIVE HEARING LOSS
    • 7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEARING AIDS AND INCREASING PRODUCT APPROVALS TO PROPEL MARKET GROWTH
    • TABLE 101 HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 102 HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION, 2020-2026 (USD MILLION)

8 HEARING AIDS MARKET, BY PATIENT TYPE

  • 8.1 INTRODUCTION
    • TABLE 103 HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 104 HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
  • 8.2 ADULTS
    • 8.2.1 HIGHER SUSCEPTIBILITY TO HEARING LOSS MAKES ADULTS A KEY SEGMENT OF THE OVERALL PATIENT POOL
      • 8.2.1.1 Primary notes
        • 8.2.1.1.1 Key industry insights
    • TABLE 105 HEARING AIDS MARKET FOR ADULT PATIENTS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 106 HEARING AIDS MARKET FOR ADULT PATIENTS, BY REGION, 2020-2026 (USD MILLION)
  • 8.3 PEDIATRICS
    • 8.3.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 107 HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 108 HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2020-2026 (USD MILLION)

9 HEARING AIDS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 109 HEARING AIDS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 110 HEARING AIDS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 9.2 EUROPE
    • FIGURE 29 EUROPE: HEARING AIDS MARKET SNAPSHOT
    • TABLE 111 EUROPE: HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 112 EUROPE: HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 113 EUROPE: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 114 EUROPE: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 115 EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 116 EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • 9.2.1 GERMANY
      • 9.2.1.1 Growth in healthcare expenditure in Germany to drive the demand for technologically advanced hearing aids
    • FIGURE 30 PREVALENCE OF HEARING LOSS IN GERMANY, 2015 VS. 2018
    • FIGURE 31 ADOPTION RATE OF HEARING AIDS BY HEARING-IMPAIRED PEOPLE IN GERMANY, 2012 VS. 2015 VS. 2018
    • TABLE 117 GERMANY: KEY MACROINDICATORS
    • TABLE 118 GERMANY: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 119 GERMANY: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 120 GERMANY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 121 GERMANY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 122 GERMANY: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 123 GERMANY: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
    • 9.2.2 UK
      • 9.2.2.1 High and growing prevalence of hearing loss to drive market growth in the UK
    • TABLE 124 UK: KEY MACROINDICATORS
    • TABLE 125 UK: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 126 UK: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 127 UK: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 128 UK: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 129 UK: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 130 UK: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
    • 9.2.3 FRANCE
      • 9.2.3.1 Rising R&D expenditure in France to drive the market growth
    • FIGURE 32 ADOPTION RATE OF HEARING AIDS BY HEARING-IMPAIRED PEOPLE IN FRANCE, 2012 VS. 2015 VS. 2018
    • TABLE 131 FRANCE: KEY MACROINDICATORS
    • TABLE 132 FRANCE: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 133 FRANCE: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 134 FRANCE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 135 FRANCE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 136 FRANCE: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 137 FRANCE: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
    • 9.2.4 SPAIN
      • 9.2.4.1 Increasing life expectancy and growing geriatric population to drive market growth in Spain
    • FIGURE 33 SPAIN: PREVALENCE OF HEARING LOSS IN 2020, BY AGE GROUP
    • TABLE 138 SPAIN: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 139 SPAIN: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 140 SPAIN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 141 SPAIN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 142 SPAIN: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 143 SPAIN: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
    • 9.2.5 ITALY
      • 9.2.5.1 Unfavorable reimbursement scenario to restrain market growth in Italy to a certain extent
    • FIGURE 34 PREVALENCE OF HEARING LOSS IN ITALY, 2012 VS. 2015 VS. 2018
    • FIGURE 35 HEARING AIDS ADOPTION RATE IN ITALY, 2012 VS. 2015 VS. 2018
    • TABLE 144 ITALY: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 145 ITALY: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 146 ITALY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 147 ITALY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 148 ITALY: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 149 ITALY: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
    • 9.2.6 REST OF EUROPE
    • TABLE 150 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
    • TABLE 151 ROE: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 152 ROE: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 153 ROE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 154 ROE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 155 ROE: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 156 ROE: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
  • 9.3 NORTH AMERICA
    • TABLE 157 NORTH AMERICA: HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 158 NORTH AMERICA: HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 159 NORTH AMERICA: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 160 NORTH AMERICA: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 161 NORTH AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 162 NORTH AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • 9.3.1 US
      • 9.3.1.1 The US dominated the North American hearing aids market in 2020
    • FIGURE 36 NUMBER OF AUDIOLOGISTS IN THE US
    • TABLE 163 US: KEY MACROINDICATORS
    • TABLE 164 US: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 165 US: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 166 US: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 167 US: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 168 US: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 169 US: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
    • 9.3.2 CANADA
      • 9.3.2.1 Conferences, webinars, and symposia to provide impetus to the market growth
    • TABLE 170 CANADA: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 171 CANADA: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 172 CANADA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 173 CANADA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 174 CANADA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 175 CANADA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 37 ASIA PACIFIC: HEARING AIDS MARKET SNAPSHOT
    • TABLE 176 APAC: HEARING AIDS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 177 APAC: HEARING AIDS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 178 APAC: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 179 APAC: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 180 APAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 181 APAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 China dominated the APAC market for hearing aids in 2020
    • TABLE 182 CHINA: KEY MACROINDICATORS
    • TABLE 183 CHINA: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 184 CHINA: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 185 CHINA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 186 CHINA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 187 CHINA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 188 CHINA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
    • 9.4.2 INDIA
      • 9.4.2.1 Healthcare infrastructure improvements to drive market growth in India
    • TABLE 189 INDIA: KEY MACROINDICATORS
    • TABLE 190 INDIA: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 191 INDIA: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 192 INDIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 193 INDIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 194 INDIA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 195 INDIA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
    • 9.4.3 JAPAN
      • 9.4.3.1 Rising adoption of hearing aids in the country to support market growth
    • FIGURE 38 HEARING AIDS ADOPTION RATE IN JAPAN, 2012 VS. 2015 VS. 2018
    • TABLE 196 JAPAN: KEY MACROINDICATORS
    • TABLE 197 JAPAN: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 198 JAPAN: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 199 JAPAN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 200 JAPAN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 201 JAPAN: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 202 JAPAN: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
    • 9.4.4 AUSTRALIA
      • 9.4.4.1 Rising geriatric population to drive market growth in Australia
    • FIGURE 39 DISTRIBUTIVE SHARE OF POPULATION IN AUSTRALIA, BY AGE GROUP, 2016 VS. 2019
    • TABLE 203 AUSTRALIA: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 204 AUSTRALIA: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 205 AUSTRALIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 206 AUSTRALIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 207 AUSTRALIA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 208 AUSTRALIA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
    • 9.4.5 REST OF ASIA PACIFIC
    • FIGURE 40 DISTRIBUTIVE SHARE OF POPULATION IN TAIWAN, BY AGE GROUP, 2016 VS. 2019
    • TABLE 209 ROAPAC: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 210 ROAPAC: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 211 ROAPAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 212 ROAPAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 213 ROAPAC: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 214 ROAPAC: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 INCREASING EFFORTS TO IMPLEMENT UNIVERSAL HEALTH COVERAGE IN THE REGION TO SUPPORT MARKET GROWTH
    • FIGURE 41 NUMBER OF PEOPLE WITH DISABLING HEARING LOSS IN BRAZIL AND MEXICO, 2008 VS. 2018
    • TABLE 215 LATIN AMERICA: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 216 LATIN AMERICA: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 217 LATIN AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 218 LATIN AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 219 LATIN AMERICA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 220 LATIN AMERICA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 HEALTHCARE INFRASTRUCTURE IMPROVEMENTS IN THE REGION TO DRIVE MARKET GROWTH
    • TABLE 221 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 222 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 223 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016-2019 (USD MILLION)
    • TABLE 224 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020-2026 (USD MILLION)
    • TABLE 225 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PATIENT TYPE, 2016-2019 (USD MILLION)
    • TABLE 226 MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PATIENT TYPE, 2020-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE HEARING AIDS MARKET
    • TABLE 227 OVERVIEW OF STRATEGIES DEPLOYED BY KEY HEARING AIDS MANUFACTURING COMPANIES
  • 10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 42 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE HEARING AIDS MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 43 HEARING AIDS MARKET SHARE, BY KEY PLAYER (2020)
    • TABLE 228 HEARING AIDS MARKET: DEGREE OF COMPETITION
  • 10.5 COMPANY EVALUATION QUADRANT
    • 10.5.1 LIST OF EVALUATED VENDORS
    • 10.5.2 STARS
    • 10.5.3 EMERGING LEADERS
    • 10.5.4 PERVASIVE PLAYERS
    • 10.5.5 PARTICIPANTS
    • FIGURE 44 HEARING AIDS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
  • 10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020)
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 DYNAMIC COMPANIES
    • FIGURE 45 HEARING AIDS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020
  • 10.7 COMPETITIVE BENCHMARKING
    • 10.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
    • FIGURE 46 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE HEARING AIDS MARKET
    • TABLE 229 PRODUCT FOOTPRINT OF COMPANIES
    • TABLE 230 REGIONAL FOOTPRINT OF COMPANIES
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 PRODUCT LAUNCHES & REGULATORY APPROVALS
    • TABLE 231 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
    • 10.8.2 DEALS
    • TABLE 232 KEY DEALS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View)**
    • 11.1.1 SONOVA GROUP
    • TABLE 233 SONOVA GROUP: BUSINESS OVERVIEW
    • FIGURE 47 SONOVA GROUP: COMPANY SNAPSHOT (2020)
    • 11.1.2 DEMANT A/S
    • TABLE 234 DEMANT A/S: BUSINESS OVERVIEW
    • FIGURE 48 DEMANT A/S: COMPANY SNAPSHOT (2020)
    • 11.1.3 GN STORE NORD A/S
    • TABLE 235 GN STORE NORD A/S: BUSINESS OVERVIEW
    • FIGURE 49 GN STORE NORD A/S: COMPANY SNAPSHOT (2020)
    • 11.1.4 COCHLEAR LTD.
    • TABLE 236 COCHLEAR LTD.: BUSINESS OVERVIEW
    • FIGURE 50 COCHLEAR LTD.: COMPANY SNAPSHOT (2020)
    • 11.1.5 RION CO., LTD.
    • TABLE 237 RION CO., LTD.: BUSINESS OVERVIEW
    • FIGURE 51 RION CO., LTD.: COMPANY SNAPSHOT (2020)
    • 11.1.6 STARKEY
    • TABLE 238 STARKEY: BUSINESS OVERVIEW
    • 11.1.7 WS AUDIOLOGY A/S
    • TABLE 239 WS AUDIOLOGY A/S: BUSINESS OVERVIEW
    • 11.1.8 NUROTRON BIOTECHNOLOGY CO., LTD.
    • TABLE 240 NUROTRON BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
    • 11.1.9 MED-EL
    • TABLE 241 MED-EL: BUSINESS OVERVIEW
    • 11.1.10 AUDINA HEARING INSTRUMENTS, INC.
    • TABLE 242 AUDINA HEARING INSTRUMENTS, INC.: BUSINESS OVERVIEW
    • 11.1.11 ELKON PVT. LTD.
    • TABLE 243 ELKON PVT. LTD.: BUSINESS OVERVIEW
  • * Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
  • 11.2 OTHER PLAYERS
    • 11.2.1 EARGO, INC.
    • 11.2.2 HORENTEK
    • 11.2.3 ZOUNDS HEARING INC.
    • 11.2.4 SEBOTEK HEARING SYSTEMS, LLC.
    • 11.2.5 ARPHI ELECTRONICS PRIVATE LIMITED
    • 11.2.6 IN4 TECHNOLOGY CORPORATION
    • 11.2.7 BHM-TECH PRODUKTIONSGESELLSCHAFT MBH
    • 11.2.8 NANO HEARING AIDS
    • 11.2.9 LORECA S.R.O.
    • 11.2.10 EARLENS CORPORATION
    • 11.2.11 AUSTAR HEARING SCIENCE AND TECHNOLOGY (XIAMEN) CO., LTD.
    • 11.2.12 LIVELY HEARING CORPORATION
    • 11.2.13 AUDIFON GMBH & CO. KG
    • 11.2.14 FOSHAN VOHOM TECHNOLOGY CO., LTD.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS